Investigations on the metabolic stability of cytosolic phospholipase A(2)alpha inhibitors with 1-indolylpropan-2-one structure

Abstract : Cytosolic phospholipase A(2)alpha (cPLA(2)alpha) plays a key role in the pathogenesis of many inflammatory diseases, such as rheumatoid arthritis, atopic dermatitis and Alzheimer's disease. Therefore, inhibition of this enzyme is assumed to provide a novel therapeutic option for the treatment of these maladies. In this study we investigated the metabolism of the potent cPLA(2)alpha inhibitors 1-[3-(4-phenoxyphenoxy)-2-oxopropyl]indole-5-carboxylic acid (1) and 3-isobutanoyl-1-[3-(4-phenoxyphenoxy)-2-oxopropyl]indole-5-carboxylic acid (2). Incubation of 1 with a mixture of human recombinant CYP1A2, 2C8, 2C9, 2C19, 2D6, 3A4 and NADPH-cytochrome P450 reductase enzymes led to reduction of its keto group and to hydroxylation at the terminal phenoxy residue. To identify the enzymes responsible for the observed reactions, experiments with isoform inhibitors were performed. In rat liver S9 fractions the only metabolite found was the alcohol 3 formed by the reduction of the keto group of I. This reaction here was mainly catalyzed by cytosolic short-chain dehydrogenases/reductases (cSDR) as shown by inhibition experiments with different carbonyl reductase inhibitors. Furthermore, the metabolic stability of 2 in mouse brains was studied after intracerebroventricular application of this compound into the right brain hemispheres of mice. HPLC/MS analyses revealed that 2 is also readily reduced in the brain to an inactive alcohol metabolite most likely by carbonyl reductases.
Type de document :
Article dans une revue
Chemico-Biological Interactions, Elsevier, 2013, 206 (2), pp.356-363. 〈10.1016/j.cbi.2013.10.005〉
Liste complète des métadonnées

https://hal.univ-lorraine.fr/hal-01561295
Contributeur : Urafpa Ul <>
Soumis le : mercredi 12 juillet 2017 - 15:51:15
Dernière modification le : lundi 19 mars 2018 - 15:08:30

Identifiants

Collections

Citation

Joerg Fabian, Walburga Hanekamp, Melanie H. Thomas, Jean Luc Olivier, Matthias Lehr. Investigations on the metabolic stability of cytosolic phospholipase A(2)alpha inhibitors with 1-indolylpropan-2-one structure. Chemico-Biological Interactions, Elsevier, 2013, 206 (2), pp.356-363. 〈10.1016/j.cbi.2013.10.005〉. 〈hal-01561295〉

Partager

Métriques

Consultations de la notice

137